ConductScience.org, home

Paper229798

Role of envelope proteins of paramyxoviruses in the modification of cell membrane antigens.

Eaton MD. Arch Virol, 1979. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Role of envelope proteins of paramyxoviruses in the modification of cell membrane antigens. Papers, record 229798. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/229798

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of envelope proteins of paramyxoviruses in the modification of cell membrane antigens.
PubMed
Journal
Arch Virol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.04
iCite
Revised in PubMed
2019-08-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eaton MDM D

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Antigens, SurfaceMajor topic
LymphomaMajor topic
ParamyxoviridaeMajor topic
Viral ProteinsMajor topic
Animals
Antibodies, Neoplasm
Antigens, Viral
Female
Male
Mice
Neoplasms, Experimental
Newcastle disease virus
Parainfluenza Virus 1, Human

Source PubMed

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,361,457Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.Virology1974https://conductscience.org/library/papers/4361457PubMed
24,337,169Solubilization of envelopes of HVJ (Sendai virus) with alkali-emasol treatment and reassembly of envelope particles with removal of the detergent.J Virol1972https://conductscience.org/library/papers/4337169PubMed
34,296,249Poliovirus replication and cytopathogenicity in monolayer hamster cell cultures fused with beta propiolactone-inactivated Sendai virus.Proc Soc Exp Biol Med1968https://conductscience.org/library/papers/4296249PubMed
4189,082Assembly of viral membranes. I. Association of vesicular stomatitis virus membrane proteins and membranes in a cell-free system.J Virol1977https://conductscience.org/library/papers/189082PubMed
54,306,303Interactions between Sendai virus and human erythrocytes.J Virol1969https://conductscience.org/library/papers/4306303PubMed
679,615Inductive requirements for the generation of virus-specific T lymphocytes. I. The nature of the host cell-virus interaction that triggers secondary poxvirus-specific cytotoxic T lymphocyte induction.J Immunol1978https://conductscience.org/library/papers/79615PubMed
7123,011Elution and uncoating of Coxsackievirus B3 by isolated HeLa cell plasma membranes.J Virol1975https://conductscience.org/library/papers/123011PubMed
872,108Immunologic properties of purified Sendai virus glycoproteins.J Immunol1977https://conductscience.org/library/papers/72108PubMed
94,342,078Artificial assembly of envelope particles of HVJ (Sendai virus). I. Assembly of hemolytic and fusion factors from envelopes solubilized by Nonidet P40.Virology1972https://conductscience.org/library/papers/4342078PubMed
1013,938,956Hemagglutination by measles virus. 4. A simple procedure for production of high potency antigen for hemagglutination-inhibition (HI) tests.Proc Soc Exp Biol Med1962https://conductscience.org/library/papers/13938956PubMed
11657,285Cell mediated immunity in mice immunized with modified syngeneic gross lymphoma antigen.Cell Immunol1978https://conductscience.org/library/papers/657285PubMed
1216,073,430T-cell cytotoxicity in the absence of viral protein synthesis in target cells.Nature1977https://conductscience.org/library/papers/16073430PubMed
1378,960Involvement of fusion activity of ultraviolet light-inactivated Sendai virus in formation of target antigens recognized by cytotoxic T cells.J Exp Med1978https://conductscience.org/library/papers/78960PubMed
144,357,358Enhancement of lymphoma cell immunogenicity by infection with nononcogenic virus.Cancer Res1973https://conductscience.org/library/papers/4357358PubMed
154,290,961Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus.J Exp Med1967https://conductscience.org/library/papers/4290961PubMed
164,734,650Isolation and purification of the envelope proteins of Newcastle disease virus.J Virol1973https://conductscience.org/library/papers/4734650PubMed
17319,064Autoimmunity induced by injection of virus-modified cell membrane antigens in syngeneic mice.Infect Immun1977https://conductscience.org/library/papers/319064PubMed
184,285,503Parainfluenza 2 virus: increase in hemagglutinin titer on treatment with Tween-80 and ether.Proc Soc Exp Biol Med1966https://conductscience.org/library/papers/4285503PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
7,380,556Autoimmunity induced by syngeneic splenocyte membranes carrying irreversibly adsorbed paramyxovirus.Infect Immun1980https://conductscience.org/library/papers/7380556

Source PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/229798

GET https://conductscience.org/api/papers/v1/229798/authors